News | Cardiovascular Business | December 27, 2022

CAROL Act to Expand Research Funding, Raise Awareness for Valvular Heart Disease

Photo by: Congressman Andy Barr

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, legislation introduced by Representative Andy Barr (R-KY) last year to honor the legacy of his wife, Carol Leavell Barr, who passed away in 2020 from sudden cardiac death brought on by mitral valve prolapse, an underlying heart condition that is fatal in .2% of cases.

The Society of Cardiovascular Computed Tomography (SCCT) joined over 20 other organizations including the American Heart Association and the Caregiver Action Network endorsing the bill, which provides $28 million to expand research on valvular heart disease and its treatment through the National Heart, Lung, and Blood Institute.

The legislation – which passed both the U.S. Senate and House of Representatives by unanimous vote this month – outlines efforts to take action based on research findings, including identifying and disseminating best practices for relevant health care providers and raising awareness of sudden cardiac death as a result of valvular heart diseases through prevention activities.

In a letter earlier this year to Senate Health, Education, Labor and Pensions Committee Chair Sen. Patty Murray (D-WA), the supporting societies emphasized the benefits of the legislation, including funding for life-saving research on heart valve disease; increasing efforts for screening, detection, and diagnosis of heart valve disease; and expanding the out-of-hospital cardiac arrest registry data collection, Cardiac Arrest Registry to Enhance Survival (CARES).

“This bill will fund critical breakthroughs in our understanding of valvular heart disease, improve our knowledge of this poorly understood condition, and someday produce a cure,” said Congresswoman Kathleen Rice (D-NY), lead cosponsor of the CAROL Act, in an earlier statement. “I commend Rep. Barr and his family for their incredible strength and for turning grief into action.”

Along with SCCT, the CAROL Act was endorsed by Adult Congenital Heart Association; Alliance for Aging Research; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Cardiology; American College of Emergency Physicians; American Heart Association; Association of Black Cardiologists; CardioVisual; Caregiver Action Network; Children's Cardiomyopathy Foundation (CCF); HealthyWomen; Heart Valve Voice US; Hypertrophic Cardiomyopathy Association; Medical Management Associates, Inc.; Preventive Cardiovascular Nurses Association; Society for Cardiovascular Angiography and Interventions; Society for Women's Health Research; StopAfib.org/American Foundation for Women's Health; Sustainable Cardiovascular Health Equity Development Alliance; The Marfan Foundation; The Mended Hearts. Inc.; Women First Research Coalition; and WomenHeart: The National Coalition for Women with Heart Disease.

For more information: www.scct.org 

Related content: CAROL Act Will Prioritize Research on Heart Valve Disease

 


Related Content

Feature | Heart Failure | Kyle Hardner

Editor's Note: This is Part Three of a three-part series highlighting several of the presentations from the American ...

Home May 13, 2026
Home
News | Heart Failure

May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...

Home May 11, 2026
Home
Feature | Heart Failure | Kyle Hardner

Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...

Home May 04, 2026
Home
News | Heart Failure

April 21, 2026 — Nuwellis, Inc. has announced a software update to its Aquadex SmartFlow ultrafiltration platform. The ...

Home April 23, 2026
Home
News | Heart Failure

March 28, 2026 — Amgen announced today that Repatha (evolocumab), when added to statins or other low-density lipoprotein ...

Home April 06, 2026
Home
News | Heart Failure

March 24, 2026 — New research shows that small improvements to sleep, diet quality and physical activity, made in ...

Home March 25, 2026
Home
News | Heart Failure

March 16, 2026 — Cytokinetics has announced four presentations related to Myqorzo (aficamten) at the American College of ...

Home March 16, 2026
Home
Feature | Heart Failure | Rohit Sood, MD, PhD

Cardiovascular disease (CVD) is a serious global health burden that encompasses a broad group of diseases that affect ...

Home February 12, 2026
Home
News | Heart Failure

Feb. 3, 2026 — Bristol Myers Squibb has launched "Change the Target. Change What’s Possible," an educational campaign ...

Home February 03, 2026
Home
News | Heart Failure

Jan. 27, 2026 — A new national study reveals a stark disconnect between Americans’ desire for preventive cardiac ...

Home January 27, 2026
Home
Subscribe Now